Literature DB >> 30382318

Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR).

Y Chi1, J Sun1, L Pang1, R Jiajue1, Y Jiang1, O Wang1, M Li1, X Xing1, Y Hu1, X Zhou1, X Meng1, W Xia2.   

Abstract

Pseudovitamin D-deficiency rickets is a rare disease which is caused by CYP27B1. In this study, we identified 9 mutations in 7 PDDR patients. In addition, we observed the response to long-term treatment of calcitriol in 15 Chinese patients with PDDR, which showed that the biochemical abnormalities had been corrected satisfactorily after 1-year treatment.
INTRODUCTION: Pseudovitamin D-deficiency rickets is a rare autosomal recessive disorder resulting from a defect in 25-hydroxyvitamin D 1α-hydroxylase, which is encoded by CYP27B1. The purpose of this study was to identify the CYP27B1 mutations and investigate the response to long-term treatment of calcitriol in Chinese patients with PDDR.
METHODS: We investigated CYP27B1 mutations in seven individuals from six separate families. To investigate the response to long-term (13 years) treatment with calcitriol in PDDR patients, we additionally collected clinical data of eight families from our previous report and analyzed their biochemical parameter and radiographic changes during the treatment.
RESULTS: Nine different mutations were identified: two novel missense mutations (G194R, R259L), three novel and one reported deletion mutations (c1442delA, c1504delA, c311-321del, and c. 48-60del), two novel nonsense mutations (c.85G>T, c.580G>T), and a reported insertion mutation (c1325-1332insCCCACCC). The statistical analysis revealed that parathyroid hormone (PTH) and ALP significantly decreased after 6-month and 1-year treatment with calcitriol respectively. Urine calcium was measured in all the patients without kidney stones being documented. After 6-year treatment, the radiographic abnormalities had also been improved. Two patients who had reached their final height are both with short stature (height Z-score below - 2.0).
CONCLUSIONS: We identified seven novel mutations of CYP27B1 gene in seven Chinese PDDR families. Our findings revealed after 1-year treatment of active vitamin D3, PTH and ALP significantly decreased. The correction of the biochemical abnormalities had not improved the final height satisfactorily.

Entities:  

Keywords:  CYP27B1; Calcitriol; Mutation; Pseudovitamin D-deficiency rickets (PDDR); Treatment

Mesh:

Substances:

Year:  2018        PMID: 30382318     DOI: 10.1007/s00198-018-4607-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  21 in total

1.  A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1.

Authors:  Ali S Alzahrani; Minjing Zou; Essa Y Baitei; Omalkhaire M Alshaikh; Roua A Al-Rijjal; Brian F Meyer; Yufei Shi
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

2.  Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.

Authors:  D Zehnder; R Bland; M C Williams; R W McNinch; A J Howie; P M Stewart; M Hewison
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.

Authors:  C R Scriver; T M Reade; H F DeLuca; A J Hamstra
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

4.  Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density.

Authors:  J S Adams; V Kantorovich; C Wu; M Javanbakht; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

5.  Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1.

Authors:  Keiko Yamamoto; Eriko Uchida; Naoko Urushino; Toshiyuki Sakaki; Norio Kagawa; Natsumi Sawada; Masaki Kamakura; Shigeaki Kato; Kuniyo Inouye; Sachiko Yamada
Journal:  J Biol Chem       Date:  2005-06-22       Impact factor: 5.157

6.  Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency.

Authors:  Chan Jong Kim; Larry E Kaplan; Farzana Perwad; Ningwu Huang; Amita Sharma; Yong Choi; Walter L Miller; Anthony A Portale
Journal:  J Clin Endocrinol Metab       Date:  2007-05-08       Impact factor: 5.958

7.  Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families.

Authors:  J T Wang; C J Lin; S M Burridge; G K Fu; M Labuda; A A Portale; W L Miller
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse.

Authors:  Paul H Anderson; Ivanka Hendrix; Rebecca K Sawyer; Reza Zarrinkalam; Jim Manavis; Ghafar T Sarvestani; Brian K May; Howard A Morris
Journal:  Mol Cell Endocrinol       Date:  2008-01-16       Impact factor: 4.102

9.  Novel mutations of CYP27B1 gene lead to reduced activity of 1α-hydroxylase in Chinese patients.

Authors:  Ningyi Cui; Weibo Xia; Hua Su; Li Pang; Yan Jiang; Yue Sun; Min Nie; Xiaoping Xing; Mei Li; Ou Wang; Tao Yuan; Yue Chi; Yingying Hu; Huaicheng Liu; Xunwu Meng; Xueying Zhou
Journal:  Bone       Date:  2012-05-12       Impact factor: 4.398

10.  A novel splicing defect (IVS6+1G>T) in a patient with pseudovitamin D deficiency rickets.

Authors:  L Porcu; A Meloni; L Casula; I Asunis; M G Marini; A Cao; P Moi
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

View more
  2 in total

1.  Benefits of Newborn Screening for Vitamin D-Dependant Rickets Type 1A in a Founder Population.

Authors:  Carol-Ann Fortin; Lysanne Girard; Chloé Bonenfant; Josianne Leblanc; Tania Cruz-Marino; Marie-Eve Blackburn; Mathieu Desmeules; Luigi Bouchard
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

Review 2.  Does Genotype-Phenotype Correlation Exist in Vitamin D-Dependent Rickets Type IA: Report of 13 New Cases and Review of the Literature.

Authors:  Sare Betul Kaygusuz; Ceren Alavanda; Tarik Kirkgoz; Mehmet Eltan; Zehra Yavas Abali; Didem Helvacioglu; Tulay Guran; Pinar Ata; Abdullah Bereket; Serap Turan
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.